Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.23 USD | -2.64% | -11.25% | -34.95% |
May. 10 | UBS Trims Price Target on Amicus Therapeutics to $19 From $20, Keeps Buy Rating | MT |
May. 09 | Amicus Therapeutics' Q1 Net Loss Narrows, Net Product Sales Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.95% | 2.73B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- FOLD Stock
- News Amicus Therapeutics, Inc.
- Insider Sell: Amicus Therapeutics